Hormonal perturbations in fibromyalgia;Anomalies endocriniennes et fibromyalgie

Annales d'Endocrinologie

Volumn 62, Issue 6, 2001, Pages 542-548

  Schlienger, J L ^a   Perrin, A E ^a   Grunenberger, F ^a   Goichot, B ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Adrenergic system; Fibromyalgia; Growth hormone; Hypothalamo pituitary axis; Thyroid hormones

Indexed keywords

GROWTH HORMONE; PROLACTIN; SOMATOMEDIN C;

ADRENERGIC SYSTEM; ARTICLE; CIRCADIAN RHYTHM; ENDOCRINE DISEASE; FIBROMYALGIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MENTAL DISEASE; STRESS; THYROID FUNCTION;

ADRENOCORTICOTROPIC HORMONE; CIRCADIAN RHYTHM; CORTICOTROPIN-RELEASING HORMONE; FATIGUE; FEMALE; FIBROMYALGIA; HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MALE; PITUITARY-ADRENAL SYSTEM; PROLACTIN; SYMPATHETIC NERVOUS SYSTEM;

EID: 0035685095     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Association between chronic widespread musculo-skeletal complaints and thyroid autoimmunity. Results from a community survey
2. Reduced hypothalamic pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome
3. Elevated plasma levels of neuropeptide Y in female fibromyalgia patients
4. Low growth hormone secretion in patients with fibromyalgia. A preliminary report on 10 patients and 10 controls
5. Neurasthenia or nervous exhaustion
6. The connective tissue disease and symptoms associated with Hashimoto's thyroiditis
7. Function of the hypothalamic adrenal axis in patients with fibromyalgia syndrome undergoing mudpack treatment
8. Hypothalamic-pituitary-insulin-like growth factor-1 dysfunction in patients with fibromyalgia
9. Disordered growth hormone secretion in fibromyalgia: A review of recent findings and a hypothesized etiology
10. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia
11. Secretion of growth hormone in patients with chronic fatigue syndrome
12. Insulin-like growth factor-1 (somatomedin C) levels in chronic fatigue syndrome and fibromyalgia
13. Fibromyalgia, chronic fatigue syndrome and myofascial pain syndrome
14. Fibrositis and primary hypothyroidism
15. Fibromyalgia and sex hormones
16. A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis
17. The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis
18. Neurohormonal perturbations in fibromyalgia
19. Neuroendocrine abnormalities in fibromyalgia and related disorders
20. Stringent endocrinological listing reveals subnormal growth hormone secretion in some patients with fibromyalgia syndrome but rarely severe growth hormone deficiency
21. Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia
22. The involvement of serotonin in regulation of pituitary adrenocortical function
23. Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats
24. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome
25. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome
26. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain
27. A controlled study on serum insulin-like growth factor-1 and urinary excretion of growth hormone in fibromyalgia
28. Circadian rythms of women with fibromyalgia
29. Melatonin levels in women with fibromyalgia and chronic fatigue syndrome
30. Follicular phase hypothalamic-pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome
31. Decreased nocturnal levels of prolactin and growth hormone in women with fibromyalgia
32. The growth hormone (GH) - Releasing hormone GH, insuline like growth - Hormone factor-1 axis in patients with fibromyalgia syndrome
33. Glucocorticoid receptors, fibromyalgia and low back pain
34. Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome
35. Mutations in the cerb A beta 1 gene: Do they underlie euthyroid fibromyalgia
36. Increased 24 hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia
37. Diurnal hormone variation in fibromyalgia syndrome: A comparison with rheumatoid arthritis
38. Thyroid function in patients with fibromyalgia syndrome
39. Hormonal perturbations in fibromyalgia syndrome
40. Neuroendocrine and hormonal perturbations and relations to the serotoninergic system in fibromyalgia patients
41. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome
42. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones
43. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: A pilot study in fibromyalgia
44. When to diagnose fibromyalgia?
45. Plasma and urinary catecholamines in primary fibromyalgia: A controlled study